FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4233217575> ?p ?o ?g. }

• W4233217575 endingPage "444" @default.
• W4233217575 startingPage "444" @default.
• W4233217575 abstract "Congenital neutropenia (CN) is a rare inherited disorder of hematopoiesis with a 20% risk of evolving into acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Using next-generation sequencing in 31 CN patients who developed leukemia we found that 20 of the 31 patients (64.5%) had mutations in RUNX1 (runt-related transcription factor 1). Of these 20 patients, 19 had inherited mutations associated with CN. Intriguingly, the majority of patients with RUNX1 mutations (80.5%) also had acquired CSF3R (colony stimulating factor 3 receptor) mutations. Other leukemia-associated mutations (EP300, FLT3-ITD, CBL, and SUZ12) were less frequent. In eight patients, we detected two distinct heterozygous RUNX1 mutations. These mutations were localized to the splice-acceptor site of intron 4, affecting splicing of exons 3 and 4, which encode the Runt homology/DNA binding domain (RHD) of RUNX1, or solely in the RHD or were present in both RHD and trans-activation domain (TAD). In two patients, we were able to perform allele-specific analysis of RUNX1 mutations. Patient #10 had an Phe13TrpfsX14 deletion on one allele of RUNX1 and an Arg139ProfsX47 deletion on the other allele. In Patient #14, two RUNX1 mutations were on the same allele; one of the mutations (Met240Ile) was inherited from the mother and was localized two amino acids before the TAD, and the second acquired mutation (Arg139Gly) was in the RHD of RUNX1. Ten patients with RUNX1 mutations developed monosomy 7 and six patients developed trisomy 21 at diagnosis of leukemia. In contrast to their high frequency in CN evolving into AML, RUNX1 mutations were found in only 9 of 307 (2.9%) patients with de novo pediatric AML. RUNX1 mutations were mainly found in pediatric AML patients with an adverse prognosis. A sequential analysis at stages prior to overt leukemia in ten CN/AML patients showed that RUNX1 mutation is a late event in leukemogenic transformation. In 6 of 10 patients, a CSF3R mutation occurred prior to RUNX1 mutations (24-192 months prior to CN/AML for CSF3R mutations vs. 1-36 months prior to CN/AML for RUNX1 mutations). Interestingly, monosomy 7 or trisomy 21 appeared after acquisition of RUNX1 mutations and no additional chromosomal aberrations were detected by array-CGH. Single-cell analyses in two patients revealed that RUNX1 and CSF3R mutations were segregated in the same malignant clone. Moreover, functional studies demonstrated elevated G-CSF-induced proliferation with diminished myeloid differentiation of hematopoietic CD34+ cells after co-transduction with mutated RUNX1 and CSF3R, in comparison to cells transduced with mutated RUNX1 or mutated CSF3R only. The importance of RUNX1 mutations in leukemogenic transformation was substantially strengthened by the analysis of a unique family with two siblings suffering from CN that subsequently transformed to AML. In both children, cooperating RUNX1 and CSF3Rmutations were detected that were not present in healthy family members. Taken together, the high frequency and the time course of cooperating RUNX1 and CSF3R mutations in CN patients who developed leukemia suggests a unique molecular pathway of leukemogenesis similar as has been reported in the Gilliland-Griffin two-hit hypothesis for AML development. The concomitant detection of RUNX1 and CSF3Rmutations represents a useful biomarker for identifying CN patients with a high risk of progressing to leukemia or MDS. Disclosures: Schnittger: MLL Munich Leukemia Laboratory: Employment, Equity Ownership. Kohlmann:MLL Munich Leukemia Laboratory: Employment." @default.
• W4233217575 created "2022-05-12" @default.
• W4233217575 creator A5003682222 @default.
• W4233217575 creator A5011842227 @default.
• W4233217575 creator A5014066022 @default.
• W4233217575 creator A5014972329 @default.
• W4233217575 creator A5015520404 @default.
• W4233217575 creator A5019814633 @default.
• W4233217575 creator A5021161172 @default.
• W4233217575 creator A5023103715 @default.
• W4233217575 creator A5023137678 @default.
• W4233217575 creator A5026119181 @default.
• W4233217575 creator A5028349312 @default.
• W4233217575 creator A5029042248 @default.
• W4233217575 creator A5031536535 @default.
• W4233217575 creator A5031540176 @default.
• W4233217575 creator A5033741147 @default.
• W4233217575 creator A5035945818 @default.
• W4233217575 creator A5041302888 @default.
• W4233217575 creator A5042196764 @default.
• W4233217575 creator A5044415386 @default.
• W4233217575 creator A5048014889 @default.
• W4233217575 creator A5049525272 @default.
• W4233217575 creator A5062392530 @default.
• W4233217575 creator A5069566799 @default.
• W4233217575 creator A5075459915 @default.
• W4233217575 creator A5076502958 @default.
• W4233217575 creator A5077761723 @default.
• W4233217575 creator A5079520283 @default.
• W4233217575 date "2013-11-15" @default.
• W4233217575 modified "2023-10-03" @default.
• W4233217575 title "Cooperativity Of RUNX1 and CSF3R Mutations In The Development Of Leukemia In Severe Congenital Neutropenia: A Unique Pathway In Myeloid Leukemogenesis" @default.
• W4233217575 doi "https://doi.org/10.1182/blood.v122.21.444.444" @default.
• W4233217575 hasPublicationYear "2013" @default.
• W4233217575 type Work @default.
• W4233217575 citedByCount "1" @default.
• W4233217575 countsByYear W42332175752019 @default.
• W4233217575 crossrefType "journal-article" @default.
• W4233217575 hasAuthorship W4233217575A5003682222 @default.
• W4233217575 hasAuthorship W4233217575A5011842227 @default.
• W4233217575 hasAuthorship W4233217575A5014066022 @default.
• W4233217575 hasAuthorship W4233217575A5014972329 @default.
• W4233217575 hasAuthorship W4233217575A5015520404 @default.
• W4233217575 hasAuthorship W4233217575A5019814633 @default.
• W4233217575 hasAuthorship W4233217575A5021161172 @default.
• W4233217575 hasAuthorship W4233217575A5023103715 @default.
• W4233217575 hasAuthorship W4233217575A5023137678 @default.
• W4233217575 hasAuthorship W4233217575A5026119181 @default.
• W4233217575 hasAuthorship W4233217575A5028349312 @default.
• W4233217575 hasAuthorship W4233217575A5029042248 @default.
• W4233217575 hasAuthorship W4233217575A5031536535 @default.
• W4233217575 hasAuthorship W4233217575A5031540176 @default.
• W4233217575 hasAuthorship W4233217575A5033741147 @default.
• W4233217575 hasAuthorship W4233217575A5035945818 @default.
• W4233217575 hasAuthorship W4233217575A5041302888 @default.
• W4233217575 hasAuthorship W4233217575A5042196764 @default.
• W4233217575 hasAuthorship W4233217575A5044415386 @default.
• W4233217575 hasAuthorship W4233217575A5048014889 @default.
• W4233217575 hasAuthorship W4233217575A5049525272 @default.
• W4233217575 hasAuthorship W4233217575A5062392530 @default.
• W4233217575 hasAuthorship W4233217575A5069566799 @default.
• W4233217575 hasAuthorship W4233217575A5075459915 @default.
• W4233217575 hasAuthorship W4233217575A5076502958 @default.
• W4233217575 hasAuthorship W4233217575A5077761723 @default.
• W4233217575 hasAuthorship W4233217575A5079520283 @default.
• W4233217575 hasConcept C104317684 @default.
• W4233217575 hasConcept C109159458 @default.
• W4233217575 hasConcept C180754005 @default.
• W4233217575 hasConcept C203014093 @default.
• W4233217575 hasConcept C2778193527 @default.
• W4233217575 hasConcept C2778461978 @default.
• W4233217575 hasConcept C2778729363 @default.
• W4233217575 hasConcept C28328180 @default.
• W4233217575 hasConcept C2910090564 @default.
• W4233217575 hasConcept C45091340 @default.
• W4233217575 hasConcept C501734568 @default.
• W4233217575 hasConcept C502942594 @default.
• W4233217575 hasConcept C54355233 @default.
• W4233217575 hasConcept C86803240 @default.
• W4233217575 hasConcept C89560881 @default.
• W4233217575 hasConceptScore W4233217575C104317684 @default.
• W4233217575 hasConceptScore W4233217575C109159458 @default.
• W4233217575 hasConceptScore W4233217575C180754005 @default.
• W4233217575 hasConceptScore W4233217575C203014093 @default.
• W4233217575 hasConceptScore W4233217575C2778193527 @default.
• W4233217575 hasConceptScore W4233217575C2778461978 @default.
• W4233217575 hasConceptScore W4233217575C2778729363 @default.
• W4233217575 hasConceptScore W4233217575C28328180 @default.
• W4233217575 hasConceptScore W4233217575C2910090564 @default.
• W4233217575 hasConceptScore W4233217575C45091340 @default.
• W4233217575 hasConceptScore W4233217575C501734568 @default.
• W4233217575 hasConceptScore W4233217575C502942594 @default.
• W4233217575 hasConceptScore W4233217575C54355233 @default.
• W4233217575 hasConceptScore W4233217575C86803240 @default.
• W4233217575 hasConceptScore W4233217575C89560881 @default.
• W4233217575 hasIssue "21" @default.
• W4233217575 hasLocation W42332175751 @default.
• W4233217575 hasOpenAccess W4233217575 @default.

• next